- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Tailored Cancer Treatment Plans May Be Latest Trend
Personalized care plans will provide doctors and hospitals better understanding of cancer patients' past treatment, and what future treatments they should consider. These written care plans will help cancer patients navigate life. Philly.com reports:
Four decades after President Richard Nixon signed the National Cancer Act declaring war on cancer, there are 14 million cancer survivors in America - a number expected to climb to between 18 million and 20 million over the next decade.
"Much of the focus for years has been, 'Let's just get them to survive,' " said James Metz, vice chairman of radiation oncology at the University of Pennsylvania's Abramson Cancer Center.
"Many survivors are now kind of like, 'What's next?' It has become a big issue."
What's next are what's called personalized care plans - basically written summaries, quite detailed but in plain English, of patients' past treatment and what they should look for in the future. In other words, a single document designed to help survivors navigate life after cancer.
Doctors and hospitals are turning their attention to developing the plans, spurred on by a mandate from the Commission on Cancer that accredited cancer centers must provide a survivor care plan to every patient beginning Jan. 1, 2015.
Read the full story here: http://bit.ly/1bJiDLG
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Combatting Misconceptions of Clinical Trials to Improve Patient Participation
October 16th 2024There are many misconceptions patients might have about clinical trials that prevent them from participating, and it’s important to understand what they are in order to overcome them, said Terry L. Keys, of University of Kentucky Markey Cancer Center.
Read More
Creating Equitable Cancer Care for Americans of Asian and Pacific Islander Heritage
October 15th 2024Naoto T. Ueno, MD, PhD, FACP, of the University of Hawai’I Cancer Center outlines the underrepresentation in clinical trials, the lack of permanent medical oncologists, and issues of trust affecting care for the populations living in Hawaii.
Read More
